Trials / Conditions / Adenosine Deaminase Deficiency

Adenosine Deaminase Deficiency

9 registered clinical trials studyying Adenosine Deaminase Deficiency — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunog NCT05300373	TRPHARM	—
Unknown	Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA) NCT05300347	TRPHARM	—
Unknown	Investigation of ADA Enzyme Deficiency NCT05300334	TRPHARM	—
Enrolling By Invitation	An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID NCT04049084	University of California, Los Angeles	—
Completed	EZN-2279 in Patients With ADA-SCID NCT01420627	Leadiant Biosciences, Inc.	Phase 3
Completed	Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ NCT02022696	National Human Genome Research Institute (NHGRI)	Phase 1
Completed	Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency NCT01380990	Great Ormond Street Hospital for Children NHS Foundation Trust	Phase 1 / Phase 2
Completed	Gene Therapy ADA Deficiency NCT01279720	Great Ormond Street Hospital for Children NHS Foundation Trust	Phase 1 / Phase 2
Completed	Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Com NCT00008450	Fred Hutchinson Cancer Center	Phase 1